Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Five modifiable risk factors are associated with cardiovascular disease and death from any cause. Studies using individual-level data to evaluate the regional and sex-specific prevalence of the risk factors and their effect on these outcomes are lacking. METHODS: We pooled and harmonized individual-level data from 112 cohort studies conducted in 34 countries and 8 geographic regions participating in the Global Cardiovascular Risk Consortium. We examined associations between the risk factors (body-mass index, systolic blood pressure, non-high-density lipoprotein cholesterol, current smoking, and diabetes) and incident cardiovascular disease and death from any cause using Cox regression analyses, stratified according to geographic region, age, and sex. Population-attributable fractions were estimated for the 10-year incidence of cardiovascular disease and 10-year all-cause mortality. RESULTS: Among 1,518,028 participants (54.1% of whom were women) with a median age of 54.4 years, regional variations in the prevalence of the five modifiable risk factors were noted. Incident cardiovascular disease occurred in 80,596 participants during a median follow-up of 7.3 years (maximum, 47.3), and 177,369 participants died during a median follow-up of 8.7 years (maximum, 47.6). For all five risk factors combined, the aggregate global population-attributable fraction of the 10-year incidence of cardiovascular disease was 57.2% (95% confidence interval [CI], 52.4 to 62.1) among women and 52.6% (95% CI, 49.0 to 56.1) among men, and the corresponding values for 10-year all-cause mortality were 22.2% (95% CI, 16.8 to 27.5) and 19.1% (95% CI, 14.6 to 23.6). CONCLUSIONS: Harmonized individual-level data from a global cohort showed that 57.2% and 52.6% of cases of incident cardiovascular disease among women and men, respectively, and 22.2% and 19.1% of deaths from any cause among women and men, respectively, may be attributable to five modifiable risk factors. (Funded by the German Center for Cardiovascular Research (DZHK); ClinicalTrials.gov number, NCT05466825.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As well as the significant improvement in diabetic control, cardiometabolic risk was also improved by a significant reduction in SBP which was recorded across the cohort, specifically for those who had one or more co-existing medical conditions and for those who had a diagnosis of T2D of less than 6 years29.”
From mHealth low carbohydrate dietary intervention ameliorates glycaemic profile, blood pressure and weight status in people with type 2 diabetes (2025) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.010 · Cited by 11,449
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
(2010) · University of Twente Research Information · Cited by 6,037
Auditory and non-auditory effects of noise on health
Basner, M., Babisch, W., Davis, A., Brink, M., Clark, C., Janssen, S., & Stansfeld, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61613-x · Cited by 2,473 · cited 1×
“Environmental and exposomal factors such as physical activity 18 , alcohol consumption 28 , air pollution 29 , climate and noise 30 , educational level 3 or psychosocial risk factors including depression 31 impact CVD risk.”
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330 · cited 3×
“While tobacco consumption is strongly associated with premature mortality, elevated blood pressure and cholesterol are more specifically related to CVD. 7 A tailored reduction in the burden of CVD and all-cause mortality for persons and populations can be achieved with better understanding of the region-and sex-specif…”
InfluentialEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296 · cited 1×
“Although very low non-HDL cholesterol concentrations are related to reduced CVD events, 25,26 some observations point towards higher all-cause mortality rates in individuals with very low levels at least in longer-term follow-up.”
The Global Burden of Cardiovascular Diseases and Risk
Vaduganathan, M., Mensah, G. A., Turco, J. V., Fuster, V., & Roth, G. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.005 · Cited by 2,217
Cited by
Items 701–800 of 980
Introduction to environmental determinants of cardiovascular disease
(2025) · Elsevier eBooks · doi:10.1016/b978-0-443-43938-4.00003-x
MORTALIDADE POR DOENÇAS DO SISTEMA CIRCULATÓRIO NO PARAGUAI: ANÁLISE POR GRUPOS ETÁRIOS (2016–2021)
Oliveira, F. C. D., & Baez, A. R. (2025) · Aracê. · doi:10.56238/arev7n10-044
Heng, K. J., Loong, S. S. E., Chew, H. S. J., Yap, J. J. L., Cader, F. A., Prajapati, D., Lee, D. P. H., Shariff, R. E. R., Cuenza, L. R., Honda, S., et al. (2025) · Postgraduate Medical Journal · doi:10.1093/postmj/qgaf173
Wang, Y., Liu, G., Lu, Z., Xi, J., Feng, W., Ma, Y., Lyu, J., & Xie, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1602666
Kornelius, E., Hu, T., Chiao, C., Hwang, J., & Chan, T. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200537
Cigarette smoking upregulates vascular expression of the novel atherosclerosis risk factor ADAMTS-7Preprint
Abrahamian, C., Sharifi, M. A., Dang, T. A., Moggio, A., Winkler, M. J., Riechel, J., Winter, H., Vilne, B., Kraut, S., Hadžić, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.28.685237
Liu, L., Wang, F., Jiang, L., Liu, T., Dong, L., Zhang, T., & Hu, G.-L. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1677194
Gong, Y., Qin, Q., Sui, Y., Li, J., Ding, S., & Zheng, Y. (2025) · BMC Public Health · doi:10.1186/s12889-025-24942-z
Tinsel, I., Schmoor, C., Börger, M., Kamp, M., Hardt, H., Rakebrandt, A., Kloppe, T., Gräfe, W., Kutter, S., Riemenschneider, H., et al. (2025) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2025.0203 · Cited by 1
The Impact of Selected Risk Factors on the Frequency of Cardiac Rehabilitation: Part I
Kleinrok, A., Krawczyk-Suszek, M., & Zams, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14238289
Hypertonie im Alter: eine individualisierte Herausforderung zwischen Evidenz und klinischer Realität
Vonend, O., Bajmak, R., & Scholz, S. (2025) · Aktuelle Kardiologie · doi:10.1055/a-2708-2216
Wang, Z., Yang, L., Zhao, S., Ba, Z., Liu, M., Zhu, Y., Chen, H. D., Gao, X., & Wu, Y. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02099-8 · Cited by 1
Cardiovascular risk factors in diabetic internet users – comparative analysis
Trzeciak, B. G., Gutknecht, P. G., Grymek, S., & Siebert, J. (2025) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.02586
Inter-Patient Arrhythmia Classification via Cloud-Edge-End Multimedia Architecture
Luo, J., Cheng, Y., & Xie, C. (2025) · ACM International Conference on Multimedia in Asia (MMAsia) · doi:10.1145/3743093.3770995
Masrouri, S., Ebrahimi, N., Zooravar, D., Shapiro, M. D., Azizi, F., & Hadaegh, F. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.12.006
The McCance Brain Care Score and Mortality: Evidence From a Large‐Scale Population‐Based Cohort
Xu, Z., Wang, X., & Li, N. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70256
“Studies have found that common modifiable factors such as body mass index (BMI), waist circumference (WC), hypertension, and hyperlipidemia are associated with mortality risk [27–29].”
Piccini, D. M., Broder, E. V., & Mantilla, L. (2025) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v93.i5.20926
Cui, C., Liu, L., Qi, Y., Han, N., Xu, H., Wang, Z., Shang, X., Han, T., Zha, Y., Wei, X., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26717256
Dahl, M., Andersen, J. W., Lindholt, J., Krarup, N. T., Borregaard, B., Uberg, N., & Høgh, A. L. (2024) · Figshare · doi:10.6084/m9.figshare.26748782
The role of adipocyte Nfe2l1 in cholesterol homeostasis and atherogenesis
Jethwa, C. (2025) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.34958
Li, Z., Gao, Y., Lu, Q., Yin, Z., Zhang, S., Zhang, W., Sui, Y., Xu, Y., Li, J., Dou, K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25770293
Dahl, M., Andersen, J. W., Lindholt, J., Krarup, N. T., Borregaard, B., Uberg, N., & Høgh, A. L. (2024) · Figshare · doi:10.6084/m9.figshare.26748779
The influence of the CAD-gene SVEP1 on atherosclerosis
Winkler, M. J., Schunkert, H., & München, T. U. (2024)
Factores de riesgo relacionados con el infarto de miocardio en pacientes menores de 45 años
Fonseca, L. M. D. L. T., Castro, R. A. G., Pacheco-Naranjo, A. M., Pucha-Pesántez, R. E., Penagos, J. S. E., Carreño, J. R. C., & Cedeño, R. A. (2025) · Revista cubana de medicina militar
В., З. А., П., С. Т., & Н., М. Н. (2025) · Social Aspects of Population Health · doi:10.21045/2071-5021-2025-71-3-8
Rosado, R. J. C. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Seldén Andreasson, A., & Österblom, U. (2024) · Sophiahemmet University Library (Sophiahemmet University)
Clinical Significance of D-dimer and Lipid Profile Alterations in Patients with Heart Disease
Abdulsalam, R. K., Shukr, S. M., & Mahmoud, H. M. (2025) · American Journal of Biology and Natural Sciences · doi:10.51699/ajbns.v2i9.1467
Geschlechtersensible Gefäßmedizin
Freisinger, E. (2025) · Springer Reference Medizin · doi:10.1007/978-3-662-60880-7_212
Modulation of Macrophage Phenotype by Platelets and Cyclophilin A in Cardiovascular Inflammation
Rosa, A. (2025) · Online Publication Service of Würzburg University (Würzburg University) · doi:10.25972/opus-37533
Noh, J. S., & Roh, H. W. (2025) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2025.28.2.44
Psoriatic Arthritis Features and Risk of Cardiovascular Events: A Nationwide Cohort Study
Baez, R. S., Kavanaugh, A., Gumá, M., Kremer, J. M., & Reed, G. (2025) · Cureus · doi:10.7759/cureus.97377
Corral‐Partearroyo, C. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Okuda, N., Higashiyama, A., Tanno, K., Yonekura, Y., Miura, M., Kuno, H., Nakajima, T., Tahara, E., Morimoto, F., Sugio, K., et al. (2025) · Nutrients · doi:10.3390/nu17243856
Diabetes: A Subspecialty of Medicine and a Matter of Public Health
Conway, R. B. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s580012
Ermak, A. D., Dv, G., Kuznetsova, T. Y., Андрейченко, А. Е., Makarova, E. A., Novitskiy, R. E., & Gusev, A. V. (2025) · Vrach i informacionnye tehnologii · doi:10.25881/18110193_2025_4_86
Huber, A., Pasquier, T., Demarchi, M. S., Sadowski, S. M., Berchtold, L., Triponez, F., de Seigneux, S., & Ponte, B. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf687
Gao, F., Shi, Y., Chen, Y., & Lu, S. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250176 · Cited by 1
Hasanpour, A., Mansourzadeh, M. J., Khajavi, A., Azizi, F., & Hadaegh, F. (2025) · Intern J Endocrinol Metab · doi:10.5812/ijem-166630
A Contextual Wellness Recommender System
ELBAZ, A. A., Stitini, O., & Kaloun, S. (2026) · Statistics Optimization & Information Computing · doi:10.19139/soic-2310-5070-2766
Magdy, A., Abdelkhalek, S., Mahmoud, B., Wael, R., Ali, H. A. A., Mohamed, N., & Abdelmonem, R. (2025) · International Journal of Clinical Medical Research · doi:10.61466/ijcmr4010004 · Cited by 1
Evans, J., Dales, R., Mitchell, K., & Cakmak, S. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.127671
Abdollahpour, N., Homayounfar, N., Farsi, F., Soflaei, S. S., Rahmani, M. K., Mousavi, M., Mouhebati, M., Esmaily, H., Seifi, N., & Ghayour‐Mobarhan, M. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71351
Heart Disease Diagnosis Model Based on Machine Learning
Han, Y., Ma, R., & Liu, J. (2025) · International Symposium on Artificial Intelligence for Medicine Sciences (ISAIMS) · doi:10.1145/3777577.3777711
Wei, F., Chen, X., Yu, Z., Chen, C., Zhao, J., Dong, Y., Yu, X., & Liu, C. (2026) · Hypertension Research · doi:10.1038/s41440-025-02515-2
Xia, X., Chen, S., Tian, X., Xu, Q., Li, H., Zhang, Y., Zhang, X., Li, J., Wu, S., & Wang, A. T. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.10.022
Seed Oils as a Hypothesized Contributor to Heart Disease: A Narrative Synthesis
Mercola, J. M. (2026) · Cureus · doi:10.7759/cureus.102012 · Cited by 2
Cardiovascular health metrics among an Iranian population: insights from life’s essential 8
Kazemi, T., Jafarizadeh, R., Bizhaem, S. K., Bijari, B., & Karbasi, S. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05201-w
Benefits of Fucoxanthin in the Prevention of Chronic Diseases
Terasaki, M. (2026) · Springer eBooks · doi:10.1007/978-3-032-05253-7_11
Country-level implementation of Europe's Safe Hearts Plan for cardiovascular health
Prato, S. D., Giorgino, F., Torbeyns, B., Sargent, J. L., Karpinska, K., & Mathieu, C. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00004-5
Liu, J., Lin, S.-H., & Li, Y. (2026) · Medicine · doi:10.1097/md.0000000000047380
Homocysteine levels and cancer risk in hypertensive adults across MTHFR C677T genotypes
Li, W., Xu, G., Yang, L., Song, Y., Chen, P., Liu, L., Qu, J., & Wang, B. (2026) · Scientific Reports · doi:10.1038/s41598-026-37849-5
Næss, Ø., & Thu, H. N. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05552-y
Farmácia São Torcato - Guimarães
Brandão, I. G. G. (2025) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
A Patient-Centered Approach to Care
Gans, R. O. B. (2026) · Springer eBooks · doi:10.1007/978-3-031-82232-2_9
Li, S., Yan, C., Wu, M., Wang, T., Zhu, L., Yu, C., Zhang, W., Zhou, W., Bao, H., & Cheng, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1764481
Actigraphy-derived sleep duration and its association with blood pressure: NHANES 2011 to 2014
Armstrong, M. K., Bayly, A., Harmon, K. K., & Barreira, T. V. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004260
Shifting the Paradigm: Bringing Personalised Approaches to Coronary Artery Disease
Fathieh, S., Gray, M. P., & Figtree, G. A. (2026) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.08.030
Daba, A. K., Debiso, A. T., Atsbeha, F., & Assefa, F. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02190-5
A Comprehensive Review of Machine Learning Algorithms in Predicting Cardiovascular Diseases
Kashif, M. (2026) · Premier Journal of Cardiology · doi:10.70389/pjc.100015
Reshetov, I. V., Arutyunov, G. P., Кобалава, Ж. Д., Mishlanov, V. Y., Палеев, Ф. Н., Тимербулатов, И. Ф., Garbuzova, E. V., Livzan, M. A., Ershova, A. I., & Drapkina, O. M. (2026) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2025-4673
Sebe, A. A., Lautaoja-Kivipelto, J. H., Jokelainen, J. J., Väänänen, J., Skarp, S., Parkkila, K., Kerkelä, R., Pirinen, E., & Ukkola, O. H. (2026) · medRxiv · doi:10.64898/2026.02.10.26345983
Revolutionizing Health Monitoring: Machine Learning for Risk Factor Analysis
Meghana, P., & Sangeetha, Y. (2025) · International Conference on Emerging Research in Electronics, Computer Science and Technology (ICERECT) · doi:10.1109/icerect65215.2025.11377744
Pont, C. D., Sartorio, A., Giontella, A., Rosin, E., Cangiano, C., Zanconato, V., Marin, S., Bertucci, F., Grisenti, S., Stocchetti, F., et al. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag031
Suthar, S., Bhimani, P. D., Khali, M., & Yusuf, S. A. (2025) · Annals of Middle Eastern Medicine · doi:10.24911/amem.15-2437
Carotenoids for Healthy Longevity
Koyu, E. B. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-11608-6_21
Overcoming Psychological Barriers to Treatment Adherence
Butler, M. J., Miller, D. T., & Goodwin, A. M. (2026) · Cardiology Clinics · doi:10.1016/j.ccl.2025.11.005 · Cited by 1
Wang, S., Lin, Y., Zhao, T., Shi, X., Xiong, T., Li, R., Zheng, W., Liu, M., Li, F., Wei, J., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174332
New Advances in Cardiovascular Drugs: In Memory of Professor Akira Endo
Caturano, A. (2026) · Biomedicines · doi:10.3390/biomedicines14020487
Šidiškytė, K. (2025) · Lithuanian University of Health Sciences
Balčiūnaitė, V. (2025) · Lithuanian University of Health Sciences
Plant-Based Natural Resource Management Strategies Using Fruits for Cholesterol Regulation
Damayanti, I. A. M., Wulansari, N. T., & Megayanti, S. D. (2025) · West Science Nature and Technology · doi:10.58812/wsnt.v3i04.2630
Barkas, F., Dirou, M., Dharmayat, K., Mazidi, M., Vallejo‐Vaz, A. J., Stevens, C. A. T., Elshorbagy, A. K., & Ray, K. K. (2026) · BMC Medicine · doi:10.1186/s12916-026-04739-6
Konopásek, P., Korček, P., Kodytková, A., Pecková, M., Frantová, M., Kotaška, K., Kočí, M., Flachsová, E., Straňák, Z., Janda, J., et al. (2026) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-026-00556-8
Küçüksevgili, B., Dogru, M., Kandemir, H., Alp, Ç., & Küçüksevgili, V. (2026) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2026.2637683
Heikkilä, E. (2026) · UTUPub (University of Turku)
Association of muscle strength with abdominal aortic calcification
Li, X.-X., Wang, F.-S., Wang, H., Gao, L.-J., & Liu, K. (2026) · Journal of International Medical Research · doi:10.1177/03000605261421738
Eating behaviour and coronary heart disease: An exploratory study
Nikolić, M., Stanković, A., & Kocić, B. (2026) · Glasnik javnog zdravlja · doi:10.5937/serbjph2601071n
Lu, T., Wang, L., Chen, S., Wang, T., Sun, N., Qin, C., Yan, J., Ma, Y., Yin, H., Shen, X., et al. (2026) · Rejuvenation Research · doi:10.1177/15491684261429991
Bennouar, S., Cherif, A. B., Aoudia, Y., FISSAH, M., & Abdi, S. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104700
MicroRNAs as Biomarkers of Short-Term Complications After Cardiac Surgery
Kozik, A., Kowalewska, K. K., Piotrowski, M., Kowalewski, M., Burysz, M., & Batko, J. (2026) · Genes · doi:10.3390/genes17030326
Grossmann, E., Schilling, H., & Magnussen, C. (2026) · Current Heart Failure Reports · doi:10.1007/s11897-026-00751-2
Damigou, E., Anastasiou, C. A., Vlachopoulou, E., Kyrili, K., Barkas, F., Michelis, E., Koutsogianni, A. D., Kravvariti, E., Chrysohoou, C. A., Pitsavos, C., et al. (2025) · Journal of Atherosclerosis Prevention and Treatment · doi:10.4103/aptj.aptj_1_25
Ananth, C. V., Fields, J. C., Lee, R., Keyes, K. M., & Kostis, W. J. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004298
Modified Sleep Apnea Severity Index and Cardiovascular Risk in CPAP ‐Intolerant OSA Patients
Kaki, P. C., Goldfarb, J. A., Xu, M., Campbell, D. J., Molin, N. L., Creighton, E. W., Kaffenberger, T. M., Boon, M. S., & Huntley, C. T. (2026) · The Laryngoscope · doi:10.1002/lary.70494
Gästgivars, O., Wiklund, U., & Brunström, M. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004301
“…can predict who may benefit from preventive treatment, but they cannot discriminate which CVD outcome is most likely [4–6]. can be estimated by traditional, modifiable risk factors that account for the majority of CVD cases and are common to ischemic heart disease, stroke, and heart failure [7,8].”
Elevated Lactate-to-Albumin Ratio: A Critical Predictor of Adverse Outcomes in Coronary Syndrome
Varım, P., Çakmak, A. C., Demirci, T., Erdoğan, H., & Tatlı, E. (2026) · Konuralp Tıp Dergisi · doi:10.18521/ktd.1780067
Baťalík, L., Godula, B. J., Jelínek, L., & Sovová, E. (2026) · Cor et Vasa · doi:10.33678/cor.2025.099
The Cardiovascular Continuum Between Hypertension, Diabetes and Cardiovascular Disease
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-7717-2
Açikgönül, H., & Yıldırım, Ö. Ö. (2026) · Doğu Karadeniz Sağlık Bilimleri Dergisi · doi:10.59312/ebshealth.1790841
Memon, M. S., Qabulio, M., Basir, N., Soomro, A. K., & Naqvi, S. H. F. (2026) · VFAST Transactions on Software Engineering · doi:10.21015/vtse.v14i1.2344
Yin, Y., Jia, X., Wu, S., Qiao, H., Qin, G., Wang, T., Hu, C., Lin, H., Wang, S., Xu, Y., et al. (2026) · Life Metabolism · doi:10.1093/lifemeta/loag008
Arterial hypertension in men aged 35–74 years living in rural areas of the Novosibirsk region
Ismailova, M. A., Afanaseva, A. D., Витальевна, Г. Е., Шрамко, В. С., & Симонова, Г. И. (2026) · Ateroscleroz · doi:10.52727/2078-256x-2026-22-1-28-40
Ma, J., Zhu, B., Li, J., Zhang, X., Xu, R., Xu, F., Zhu, H., Zhang, L., Yuan, R., Cao, Y., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101612
“This necessitates the development of personalized precision prevention and evidence-based interventional strategies to reduce the "pandemic" of CVD. Targeting modifiable risk factors represents an indispensable strategy for preventing the majority of CVD and premature mortality [3 – 5].”
Cho, H.-M., Han, S., Seong, J., & Youn, I. (2026) · BioData Mining · doi:10.1186/s13040-026-00544-2
Wei, F. F., Wu, T., Deng, J., Gong, J., Zhang, S., & Cui, Z. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70245
Kmitaitė, G. (2025) · Lithuanian University of Health Sciences
Metadata
- Authors
- The Global Cardiovascular Risk Consortium
- Affiliations
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- The Global Cardiovascular Risk Consortium
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-10-05
- Volume
- 389
- Issue
- 14
- Pages
- 1273-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC10589462
- OpenAlex
- W4386194106
- Cited by
- 909
- References
- 35
- Citations by year
- 2026: 285 · 2025: 359 · 2024: 242 · 2023: 23
- FWCI
- 47.54
- Type
- journal article
- Language
- en
- Open access
- Licence
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- PubMed Central (acceptedVersion, cc-by)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lithuanian University of Health Sciences (submittedVersion, cc-by)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, other-oa)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- IrInSubria (University of Insubria) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Duo Research Archive (University of Oslo) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- European Union AFFECT-EU (Horizon 2020, No. 847770)
- German Center for Cardiovascular Research (not applicable)
- European Union MORGAM (Biomed, BMH4-CT98-3183)
- European Union GenomEUtwin (FP5, QLG2-CT-2002-01254)
- European Union ENGAGE (FP7, HEALTH-F4-2007-201413)
- European Union CHANCES (FP7, HEALTH-F3-2010-242244)
- European Union BiomarCaRE (FP7, HEALTH-F2-2011-278913)
- European Union euCanSHare (Horizon 2020, No. 825903)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- modifiable risk factors, cardiovascular disease, all-cause mortality, population attributable fraction, body mass index, systolic blood pressure, non-HDL cholesterol, smoking, diabetes mellitus, sex differences, regional variation, global cardiovascular risk, cohort studies, cardiovascular disease incidence, women's health
- MeSH terms
- Heart Disease Risk Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk Factors, Smoking, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.